tradingkey.logo

Schrodinger Inc

SDGR
18.300USD
+0.010+0.05%
Close 11/11, 16:00ETQuotes delayed by 15 min
1.35BMarket Cap
LossP/E TTM

Schrodinger Inc

18.300
+0.010+0.05%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Schrodinger Inc

Currency: USD Updated: 2025-11-11

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Schrodinger Inc's Score

Industry at a Glance

Industry Ranking
94 / 485
Overall Ranking
176 / 4608
Industry
Software & IT Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 10 analysts
Buy
Current Rating
27.000
Target Price
+47.62%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Schrodinger Inc Highlights

StrengthsRisks
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The Company operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 207.54M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is -7.62, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 71.77M shares, decreasing 2.82% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 1.96M shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-11

The company's current financial score is 6.46, which is lower than the Software & IT Services industry's average of 7.26. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 54.32M, representing a year-over-year increase of 53.94%, while its net profit experienced a year-over-year increase of 14.01%.

Score

Industry at a Glance

Previous score
6.46
Change
0

Financials

8.90

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

8.19

Operational Efficiency

3.08

Growth Potential

5.01

Shareholder Returns

7.11

Schrodinger Inc's Company Valuation

Currency: USD Updated: 2025-11-11

The company’s current valuation score is 6.79, which is lower than the Software & IT Services industry's average of 7.30. Its current P/E ratio is -7.62, which is -3321.17% below the recent high of 245.39 and -87.10% above the recent low of -14.25.

Score

Industry at a Glance

Previous score
6.79
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 94/485
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-11

The company’s current earnings forecast score is 7.80, which is higher than the Software & IT Services industry's average of 7.59. The average price target for Schrodinger Inc is 27.50, with a high of 33.00 and a low of 19.00.

Score

Industry at a Glance

Previous score
7.80
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 10 analysts
Buy
Current Rating
27.000
Target Price
+47.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

232
Total
9
Median
12
Average
Company name
Ratings
Analysts
Schrodinger Inc
SDGR
10
Microsoft Corp
MSFT
64
Palo Alto Networks Inc
PANW
55
CrowdStrike Holdings Inc
CRWD
54
Zscaler Inc
ZS
48
ServiceNow Inc
NOW
47
1
2
3
...
47

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-11

The company’s current price momentum score is 6.78, which is lower than the Software & IT Services industry's average of 6.96. Sideways: Currently, the stock price is trading between the resistance level at 21.94 and the support level at 15.73, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.81
Change
-0.03

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-0.790
Sell
RSI(14)
39.455
Neutral
STOCH(KDJ)(9,3,3)
27.238
Neutral
ATR(14)
1.089
Low Volatility
CCI(14)
-108.380
Sell
Williams %R
76.006
Sell
TRIX(12,20)
-0.188
Sell
StochRSI(14)
39.531
Buy
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
18.558
Sell
MA10
19.598
Sell
MA20
20.414
Sell
MA50
19.926
Sell
MA100
20.213
Sell
MA200
21.632
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-11

The company’s current institutional recognition score is 10.00, which is higher than the Software & IT Services industry's average of 5.80. The latest institutional shareholding proportion is 111.28%, representing a quarter-over-quarter increase of 7.89%. The largest institutional shareholder is Bill Gates, holding a total of 6.98M shares, representing 10.82% of shares outstanding, with 1.22% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
8.17M
+5.41%
Bill & Melinda Gates Foundation Trust
Star Investors
6.98M
--
The Vanguard Group, Inc.
Star Investors
6.60M
+1.15%
Rubric Capital Management LP
5.00M
+4.17%
Amova Asset Management Co., Ltd.
3.65M
+5.42%
Cadian Capital Management LP
3.05M
+175.65%
Stephens Investment Management Group, LLC
2.26M
+14.79%
State Street Investment Management (US)
2.19M
-1.18%
MFS Investment Management
1.49M
-28.60%
ARK Investment Management LLC
Star Investors
1.96M
-14.61%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-11

The company’s current risk assessment score is 5.47, which is higher than the Software & IT Services industry's average of 4.86. The company's beta value is 1.58. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.47
Change
0
Beta vs S&P 500 index
1.58
VaR
+5.71%
240-Day Maximum Drawdown
+33.38%
240-Day Volatility
+68.31%

Return

Best Daily Return
60 days
+13.83%
120 days
+13.83%
5 years
+27.42%
Worst Daily Return
60 days
-7.60%
120 days
-14.44%
5 years
-26.78%
Sharpe Ratio
60 days
-0.14
120 days
-0.36
5 years
-0.19

Risk Assessment

Maximum Drawdown
240 days
+33.38%
3 years
+69.33%
5 years
+85.64%
Return-to-Drawdown Ratio
240 days
-0.54
3 years
+0.02
5 years
-0.19
Skewness
240 days
+1.46
3 years
+0.53
5 years
+0.31

Volatility

Realised Volatility
240 days
+68.31%
5 years
+68.07%
Standardised True Range
240 days
+6.86%
5 years
+10.51%
Downside Risk-Adjusted Return
120 days
-50.17%
240 days
-50.17%
Maximum Daily Upside Volatility
60 days
+44.34%
Maximum Daily Downside Volatility
60 days
+42.01%

Liquidity

Average Turnover Rate
60 days
+1.64%
120 days
+1.65%
5 years
--
Turnover Deviation
20 days
+51.48%
60 days
+33.70%
120 days
+33.80%

Peer Comparison

Software & IT Services
Schrodinger Inc
Schrodinger Inc
SDGR
7.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
QXO Inc
QXO Inc
QXO
8.74 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amdocs Ltd
Amdocs Ltd
DOX
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Akamai Technologies Inc
Akamai Technologies Inc
AKAM
8.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
ePlus inc
ePlus inc
PLUS
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CACI International Inc
CACI International Inc
CACI
8.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI